BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38470411)

  • 1. Correction to: "Beyond MEN1, When to Think About MEN4? Retrospective Study on 5600 Patients in the French Population and Literature Review".
    J Clin Endocrinol Metab; 2024 Jun; 109(7):e1563. PubMed ID: 38470411
    [No Abstract]   [Full Text] [Related]  

  • 2. Beyond MEN1, When to Think About MEN4? Retrospective Study on 5600 Patients in the French Population and Literature Review.
    Chevalier B; Coppin L; Romanet P; Cuny T; Maïza JC; Abeillon J; Forestier J; Walter T; Gilly O; Le Bras M; Smati S; Nunes ML; Geslot A; Grunenwald S; Mouly C; Arnault G; Wagner K; Koumakis E; Cortet-Rudelli C; Merlen É; Jannin A; Espiard S; Morange I; Baudin É; Cavaille M; Tauveron I; Teissier MP; Borson-Chazot F; Mirebeau-Prunier D; Savagner F; Pasmant É; Giraud S; Vantyghem MC; Goudet P; Barlier A; Cardot-Bauters C; Odou MF
    J Clin Endocrinol Metab; 2024 Jun; 109(7):e1482-e1493. PubMed ID: 38288531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4).
    Thakker RV
    Mol Cell Endocrinol; 2014 Apr; 386(1-2):2-15. PubMed ID: 23933118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple endocrine neoplasia type 4 (MEN4): a thorough update on the latest and least known men syndrome.
    Ruggeri RM; Benevento E; De Cicco F; Grossrubatscher EM; Hasballa I; Tarsitano MG; Centello R; Isidori AM; Colao A; Pellegata NS; Faggiano A
    Endocrine; 2023 Dec; 82(3):480-490. PubMed ID: 37632635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MEN4 and
    Alrezk R; Hannah-Shmouni F; Stratakis CA
    Endocr Relat Cancer; 2017 Oct; 24(10):T195-T208. PubMed ID: 28824003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MEN1, MEN4, and Carney Complex: Pathology and Molecular Genetics.
    Schernthaner-Reiter MH; Trivellin G; Stratakis CA
    Neuroendocrinology; 2016; 103(1):18-31. PubMed ID: 25592387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline CDKN1B variant type and site are associated with phenotype in MEN4.
    Halperin R; Arnon L; Nasirov S; Friedensohn L; Gershinsky M; Telerman A; Friedman E; Bernstein-Molho R; Tirosh A
    Endocr Relat Cancer; 2023 Jan; 30(1):. PubMed ID: 36256846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A heterozygous frameshift mutation in exon 1 of CDKN1B gene in a patient affected by MEN4 syndrome.
    Tonelli F; Giudici F; Giusti F; Marini F; Cianferotti L; Nesi G; Brandi ML
    Eur J Endocrinol; 2014 Aug; 171(2):K7-K17. PubMed ID: 24819502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case Report: New CDKN1B Mutation in Multiple Endocrine Neoplasia Type 4 and Brief Literature Review on Clinical Management.
    Lavezzi E; Brunetti A; Smiroldo V; Nappo G; Pedicini V; Vitali E; Trivellin G; Mazziotti G; Lania A
    Front Endocrinol (Lausanne); 2022; 13():773143. PubMed ID: 35355569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the p27 rs2066827 variant and tumor multiplicity in patients harboring MEN1 germline mutations.
    Longuini VC; Lourenço DM; Sekiya T; Meirelles O; Goncalves TD; Coutinho FL; Francisco G; Osaki LH; Chammas R; Alves VA; Siqueira SA; Schlesinger D; Naslavsky MS; Zatz M; Duarte YA; Lebrão ML; Gama P; Lee M; Molatore S; Pereira MA; Jallad RS; Bronstein MD; Cunha-Neto MB; Liberman B; Fragoso MC; Toledo SP; Pellegata NS; Toledo RA
    Eur J Endocrinol; 2014 Sep; 171(3):335-42. PubMed ID: 24920291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple Endocrine Neoplasia: A Genetically Diverse Group of Familial Tumor Syndromes.
    Pacheco MC
    J Pediatr Genet; 2016 Jun; 5(2):89-97. PubMed ID: 27617149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p27kip1: a new multiple endocrine neoplasia gene?
    Marinoni I; Pellegata NS
    Neuroendocrinology; 2011; 93(1):19-28. PubMed ID: 20980721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MEN4, the MEN1 Mimicker: A Case Series of three Phenotypically Heterogenous Patients With Unique CDKN1B Mutations.
    Seabrook A; Wijewardene A; De Sousa S; Wong T; Sheriff N; Gill AJ; Iyer R; Field M; Luxford C; Clifton-Bligh R; McCormack A; Tucker K
    J Clin Endocrinol Metab; 2022 Jul; 107(8):2339-2349. PubMed ID: 35323929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updates on the genetics of multiple endocrine neoplasia.
    Sahakian N; Castinetti F; Romanet P; Reznik Y; Brue T
    Ann Endocrinol (Paris); 2024 Apr; 85(2):127-135. PubMed ID: 38325596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Factors Predicting Multiple Endocrine Neoplasia Type 1 and Type 4 in Patients with Neuroendocrine Tumors.
    Faggiano A; Fazzalari B; Mikovic N; Russo F; Zamponi V; Mazzilli R; Guarnieri V; Piane M; Visco V; Petrucci S
    Genes (Basel); 2023 Sep; 14(9):. PubMed ID: 37761922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A patient with MEN1 typical features and MEN2-like features.
    El-Maouche D; Welch J; Agarwal SK; Weinstein LS; Simonds WF; Marx SJ
    Int J Endocr Oncol; 2016 May; 3(2):89-95. PubMed ID: 27594983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syndromic MEN1 parathyroid adenomas consist of both subclonal nodules and clonally independent tumors.
    Bräutigam K; Nesti C; Riss P; Scheuba C; Niederle B; Grob T; Di Domenico A; Neuenschwander M; Mazal P; Köhn N; Trepp R; Perren A; Kaderli RM
    Virchows Arch; 2024 May; 484(5):789-798. PubMed ID: 38244045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of a CDKN1B mutation in a Sardinian kindred with multiple endocrine neoplasia type 4 (MEN4).
    Pardi E; Mariotti S; Pellegata NS; Benfini K; Borsari S; Saponaro F; Torregrossa L; Cappai A; Satta C; Mastinu M; Marcocci C; Cetani F
    Endocr Connect; 2015 Mar; 4(1):1-8. PubMed ID: 25416039
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.